The Effect of Topical Sunscreen Plus Antioxidant Against the Visible Light Biological Effects
- Conditions
- Pigmentation
- Interventions
- Other: Topical Product AOther: Topical Product BOther: Topical Product COther: Control
- Registration Number
- NCT03065582
- Lead Sponsor
- Henry Ford Health System
- Brief Summary
Visible light is known to induce pigmentation in darker skin types. The investigators aim to study the effects of visible light on the skin after topical application of sunscreen plus antioxidant.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 32
- Patient age 18 and older
- Patients Fitzpatrick skin phototype IV-VI
- Patient able to understand requirements of the study and risks involved
- Patient able to sign a consent form
- A recent history of vitiligo, melasma, and other disorders of pigmentation with the exception of post inflammatory hyperpigmentation
- A known history of photodermatoses
- A known history of melanoma or non-melanoma skin cancers
- Those planning on going to the tanning parlors
- Using any of the photosensitizing medication within the visible light range or additional medications at the discretion of the investigator (examples include (but not limited to) thiazide diuretics, regular use of NSAIDs, hydroxychloroquine, or voriconazole)
- A woman who is lactating, pregnant, or planning to become pregnant
- Patient planning on exposing the irradiated or control areas to the sun
- known allergy to anesthetics (lidocaine or epinephrine)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Sunscreen application Topical Product B All subjects will undergo topical application of 3 products and an additional site will serve as a control Sunscreen application Topical Product A All subjects will undergo topical application of 3 products and an additional site will serve as a control Sunscreen application Topical Product C All subjects will undergo topical application of 3 products and an additional site will serve as a control Sunscreen application Control All subjects will undergo topical application of 3 products and an additional site will serve as a control
- Primary Outcome Measures
Name Time Method diffuse reflectance spectroscopy Baseline- immediately after irradiation to assess immediate pigment darkening Diffuse reflectance spectroscopy is a non-invasive objective measure of pigmentation based on reflectance patterns of the irradiated skin
investigator's global assessment score Baseline- Immediately after irradiation to assess immediate pigment darkening The investigator's global assessment score is a non-invasive subjective measure of pigmentation in which investigators assign a value ranging between 0, corresponding with no hyperpigmentation, to 5, or severe or dark hyperpigmentation.
photography 24 hours after irradiation to assess persistent pigment darkening Cross polarized photography is used to document pigmentation non-invasively and reduce surface glare of the skin.
Diffuse reflectance spectroscopy 7 days after irradiation to assess delayed tanning Diffuse reflectance spectroscopy is a non-invasive objective measure of pigmentation based on reflectance patterns of the irradiated skin
Investigator's global assessment score 24 hours after irradiation to assess persistent pigment darkening The investigator's global assessment score is a non-invasive subjective measure of pigmentation in which investigators assign a value ranging between 0, corresponding with no hyperpigmentation, to 5, or severe or dark hyperpigmentation.
Photography 7 days after irradiation to assess delayed tanning Cross polarized photography is used to document pigmentation non-invasively and reduce surface glare of the skin.
Biological effects 24 hours after irradiation biopsy with melanocyte and melanin stains to assess pigmentation
Investigator global assessment score 7 days after irradiation to assess delayed tanning The investigator's global assessment score is a non-invasive subjective measure of pigmentation in which investigators assign a value ranging between 0, corresponding with no hyperpigmentation, to 5, or severe or dark hyperpigmentation.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Henry Ford Hospital
🇺🇸Detroit, Michigan, United States